Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Vepesid Injectable*


Contraindicated
Reproductive toxicity in animals

Contraindicated
Vepesid Injectable* :
Type Medicine Non Marketed
Originator B
Agent Pacific Pharma
Distributor Pacific Pharma
Laboratory BMS
Responsible Party Bristol-Myers Squibb GmbH
Origin Germany
Manufacturer Bristol-Myers Squibb GmbH
Origin Germany
ATC L01CB01

Your comment will appear shortly after approval

Vepesid Injectable* :

Revision Date : 24/02/2010


Effect Frequency
Acute leukaemia Common
Acute myeloid leukaemia Common
Alopecia Not known
Anaphylactic reactions Common
Hypotension Not known
Leucopenia (Leukopenia) Uncommon
Mucositis Not known
Nausea Very Common
Paraesthesia of limbs Rare
Thrombocytopenia (Thrombopenia) Rare
Vomiting Very Common

Different Units By MoH Code

Vepesid Injectable*  MoH 227 :
Form Solution for injection
Package Size 10x5ml
Strength 100mg
NSSF ✘
Quarantine ✘
Reg. Number 25982
Submission date 01/01/1986
Registration Year 1986
Archived Date 2014


Price Comparison

● Country: KSA
● Package Size: 10
● Public Price: 788.55 SAR ( 18,641,322.00 LBP )
● Pack size unit used: 10
● Cost/Unit: 78,855 SAR ( 1,843,920.00 LBP )
● Reference: sfda
● Pricing Date: 05/03/2020
● Type: Medicine Authorised

● Country: Kuweit
● Package Size: 1
● Public Price: 5.48 KWD ( 1,608,823.88 LBP )
● Pack size unit used: 1
● Cost/Unit: 5,48 KWD ( 1,467,905.00 LBP )
● Pharmacy Price: 4.63 KWD ( 1359280.03 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info